Neuropathy in COVID-19 associated with dysbiosis-related inflammation

Belma ASLIM, Büşra AKTAŞ

The effect of weekend curfews on epidemics: a Monte Carlo simulation

Hakan KAYGUSUZ, A. Nihat BERKER

Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial

Hasan ÖNAL, Seda YILMAZ SEMERCİ, Mehmet Eren KURNAZ, Nurettin SÜNER, Ali KOCATAŞ, Bengü ARSLAN, Nurcan ÜÇÜNCÜ ERGUN, Şeyma TOPUZ, Yulet Miray MOLU, Mehmet Abdussamet BOZKURT

Novel approaches for COVID-19 diagnosis and treatment: a nonsystematic review

Mehmet Dinçer BİLGİN, Hakan KAYGUSUZ, Şebnem GARİP USTAOĞLU, Feride SEVERCAN

Genomic chronicle of SARS-CoV-2: a mutational analysis with over 1 million genome sequences

Oğuz ATA, Osman Mutluhan UĞUREL, Dilek TURGUT BALIK

Host variations in SARS-CoV-2 infection

Pelin KILIÇ, Devrim DEMİR DORA, Evrim GÜNEŞ ALTUNTAŞ, Zeynep Yağmur KARAGÜLLEOĞLU, Güldane CENGİZ SEVAL, Hanife Ayşegül MENDİ, Doruk ALTIOK, Elif Zeynep SAVCI, Büşra ÖZKARA, Gizem TUNÇER, Buğrahan Regaip KILINÇ, Evren SUİÇMEZ, Güneysu ÇETİN, Dilruba Beyza UNCUOĞLU, Cansu TEKELİ, Vahdi Umut BENGİ, Si

Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?

Veysel SÜZERER, İsmail YENER, Abdulselam ERTAŞ, Mustafa Abdullah YILMAZ, Remzi EKİNCİ, Emine AYAZ TİLKAT, Sevgi İRTEGÜN KANDEMİR, Ahmet ONAY, Nesrin BOZHAN

Determination of the interaction between the receptor binding domain of 2019-nCoV spike protein, TMPRSS2, cathepsin B and cathepsin L, and glycosidic and aglycon forms of some flavonols

Erman Salih İSTİFLİ, Bektaş TEPE, Cengiz SARIKÜRKCÜ, Arzuhan ŞIHOĞLU TEPE, Paulo A. NETZ, İbrahim Halil KILIÇ

The potential use of Drosophila as an in vivo model organism for COVID-19-related research: a review

Eşref DEMİR

Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics

Zehra CAN, Yakup KARA, Sevgi KOLAYLI, Oktay YILDIZ, Halil İbrahim GÜLER, Fulya AY ŞAL, Sabriye ÇANAKÇI, Ali Osman BELDÜZ

Binary-QSAR guided virtual screening of FDA approved drugs and compounds in clinical investigation against SARS-CoV-2 main protease

Serdar DURDAĞI, Yeşim YUMAK, Lalehan OKTAY, Ece ERDEMOĞLU, İlayda TOLU, Ayşenur ÖZCAN, Elif ACAR, Şehriban BÜYÜKKILIÇ, Alpsu OLKAN

In silico drug repositioning against human NRP1 to block SARS-CoV-2 host entry

Şeref GÜL

CoronaVac (Sinovac) COVID-19 vaccine-induced molecular changes in healthy human serum by infrared spectroscopy coupled with chemometrics

Rafig GURBANOV, Feride SEVERCAN, Ayca DOĞAN, Mete SEVERCAN

β-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: computational approach

Yusuf Oloruntoyin AYIPO, Sani Najib YAHAYA, Halimah Funmilayo BABAMALE, Iqrar AHMAD, Harun PATEL, Mohd Nizam MORDI

An update comprehensive review on the status of COVID-19: vaccines, drugs, variants and neurological symptoms

Muhsin KONUK, Ebru ÖZKAN OKTAY, Tuğba KAMAN, Ömer Faruk KARASAKAL, Salih TUNCAY, Öznur Özge ÖZCAN, Tuğçe SOYLAMIŞ, Mesut KARAHAN

Pathogenesis and treatment of cytokine storm in COVID-19

Gökhan KESER, Pamir ATAGÜNDÜZ, Mehmet SOY

The current state of validated small molecules inhibiting SARS-CoV-2 nonstructural proteins

Merve USLU, Fatih KOCABAŞ